Durvalumab

Durvalumab Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Durvalumab is used to treat non-small cell lung cancer (NSCLC) that spread to nearby tissues and cannot be removed by surgery but has not worsened after being treated with other chemotherapy medications and radiation treatments. Durvalumab injection is also used in combination with etoposide (Etopophos) and either carboplatin or cisplatin to treat extensive-stage small cell lung cancer (ES-SCLC) in adults whose cancer has spread throughout the lungs and to other parts of the body.

Durvalumab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Durvalumab Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
TargetMol Chemicals Inc.	+1-781-999-5354 +1-00000000000	marketing@targetmol.com	United States	19892	58
LEAPCHEM CO., LTD.	+86-852-30606658	market18@leapchem.com	China	43348	58
SPIRO PHARMA		eric_feng1954@126.com	China	316	55
Shanghai EFE Biological Technology Co., Ltd.	021-65675885 18964387627	info@efebio.com	China	9709	58
ShangHai Biochempartner Co.,Ltd	17754423994 17754423994	2853530910@QQ.com	China	8011	62
Fan De(Beijing) Biotechnology Co., Ltd.	15911056312	liming@bio-fount.com	China	9730	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10055	58
Abmole Bioscience Inc.	021-50967598 02150967598	sales@abmole.cn	China	4495	58
Wuhan Yingnuo Pharmaceutical Technology Co., Ltd.	+86-027-59232304 15387063101	2881924050@qq.com	China	9892	58
AntibodySystem	027-65279366 18162686757	biolab-reagents@atagenix.com	China	9819	58

1428935-60-7()Verwandte Suche:

---

• Durvalumab
• MEDI4736
• Research Grade Durvalumab(DHJ70102)
• 1428935-60-7